GlassScriptPhysician profile
Brantlee Mcconaughey
NPI 1821625310
$2,051.36
in general payments reported to CMS, 2019-2025
15 companies · $801 in 2025
The $801 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $186 · 2024: $1,065 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,327 · Travel and Lodging: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.23 |
| Travel and Lodging | $724.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,021.05 | 2024-2025 | Minimed 780g |
| Abbvie INC. | $205.40 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $196.41 | 2023-2025 | |
| Novo Nordisk INC | $162.76 | 2023-2025 | Sogroya |
| Dexcom, INC. | $84.97 | 2024-2025 | Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $81.04 | 2023-2025 | Crysvita |
| Neurocrine Biosciences, INC. | $48.75 | 2024-2025 | |
| Chiesi USA, INC. | $43.78 | 2024-2025 | Myalept |
| Pfizer INC. | $43.77 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $40.99 | 2023 | Triptodur |
| Mannkind Corporation | $33.19 | 2025 | |
| Insulet Corporation | $31.51 | 2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $21.68 | 2024 | Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $19.18 | 2024 | Strensiq |
| Rhythm Pharmaceuticals, INC. | $16.88 | 2023 | Imcivree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brantlee Mcconaughey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.